NARINGENIN LOADED CYCLODEXTRIN NANOPARTICLES FOR IMPROVED DRUG DELIVERY

Author:

Adhikari Lokesh, ,Kumar Nitin,Saha Abhijit,Semalty Ajay,Semalty Mona

Abstract

Herbal drug naringenin is well known for its anti-cancer, anti-oxidant, anti-inflammatory activities, as carbohydrate metabolism promoter, immunity system modulator, BCRP/ABCG2 inhibitor, hormone substitute and hormone antagonist since decades. However, use of naringenin as pharmaceutical aid is hindered due to its low aqueous solubility. In the present study, β-cyclodextrin and hydroxy propyl -β- cyclodextrin based biocompatible nanoforms were developed by the exploitation of self-assembly properties of cyclodextrins in aqueous media using sodium dodecyl sulphate and Pluronic F108 as co-surfactants. Prepared formulations were evaluated for various parameters such as particle size, zeta potential, polydispersity index, percent encapsulation efficiency, drug solubility and in vitro permeation studies. Particles present in all the formulations were not greater than the 161.2 nm with surface charge up to -24.8 mV and highest polydispersity index of 0.739. Aqueous solubility of drugs in prepared formulations was increased by 4 fold. Drug permeability was increased twice of free drug naringenin. It was concluded that the cyclodextrin based biocompatible nanosystems can be developed in the improvement of aqueous solubility and hence the bioavailability of herbal drugs.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference22 articles.

1. 1. Wilczewska A. Z., Niemirowicz K., Markiewicz K. H. and Car H.: Nanoparticles as drug delivery systems. Pharmacol. Rep., 2012, 64, 1020-1037.

2. 2. III R.O.W. and Vaughn J. M.: Nanoparticle Engineering, in: Swarbrick, James (PharmaceuTech, Inc., Pinehurst, North Carolinia, U. (Eds.), Encyclopedia of Pharmaceutical Technology., Informa Healthcare USA, Inc., 270 Madison Avenue New York, NY, 2007, 2384-2398.

3. 3. Rizvi S. A. A. and Saleh A.M.: Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J., 2018.

4. 4. Mudshinge S. R., Deore A. B., Patil S. and Bhalgat C. M.: Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm. J., 2011.

5. 5. WHO | WHO traditional medicine strategy: 2014-2023, n.d. WHO. URL http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/ (Accessed date: 21.06.2019).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3